公司简介
About
公司简介
澳门威斯尼斯人wns615app(Suzhou Intragrand Pharma)于2019年7月成立于苏州工业园区,是由海外医药专家和行业精英所创立的医药创新公司。
澳门威斯尼斯人wns615app的目标是开发国内外尚缺乏的,在治疗炎症与神经相关等疾病领域市场未满足的小分子药品的差异化策略。
目前公司领衔研发产品有复发性咳嗽、肺纤维化、慢阻肺和哮喘等呼吸道疾病药物
Suzhou Intragrand Pharma founded in Suzhou Industrial Park in July 2019, it is a pharmaceutical innovation company founded by overseas pharmaceutical experts and industry elites. The goal of the company is to explore novel small molecule drugs to meet medical needs in the therapeutic area of inflammation and nerval associated diseases.
At present,the company leading research and development projects are the investgatigational medicines for refractory chronic cough,IPF,COPD and asthma.